TNF‐α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis patients

Conclusion: Use of TNF‐α inhibitors is associated with a decreased risk for CAD in RA; the risk decreases further with longterm use. This should be considered when weighing the risks versus benefits of these medications. © 2013 American College of Rheumatology.

Source: Arthritis Care and Research - September 10, 2013 Category: Rheumatology Authors: Androniki Bili, Xiaoqin Tang, Shruthi Pranesh, Rasa Bozaite, Stephanie J. Morris DO, Jana L. Antohe, H. Lester Kirchner, Mary Chester M. Wasko Tags: Original Article Source Type: research